Asston Pharmaceuticals IPO Date, Price ,Details
Asston Pharmaceuticals is launching its IPO, which will open for subscription on July 9, 2025, and close on July 11, 2025. This is a Book Built Issue, aiming to raise approximately ₹27.56 crores, entirely through a fresh issue of equity shares. Details regarding the offer for sale are yet to be disclosed.
The price band for the IPO is set between ₹115 to ₹123 per share. The allocation is divided as follows: 50% for Qualified Institutional Buyers (QIBs), 35% for retail investors, and 15% for High Net-worth Individuals (HNIs).
The basis of allotment is expected to be finalized by July 14, 2025, with the listing scheduled on the BSE on July 16, 2025.
On the financial front, the company reported strong growth, with revenue increasing to ₹25.61 crores in FY 2025, up from ₹15.84 crores in FY 2024. Similarly, net profit rose significantly to ₹4.33 crores in 2025 from ₹1.36 crores in 2024.
Asston Pharmaceuticals IPO Market Lot Size
The Asston Pharmaceuticals IPO minimum market lot is 2,000 shares with ₹2,46,000 application amount.
Application | Lot Size | Shares | Amount |
Retail Minimum | 2 | 2,000 | ₹2,46,000 |
Retail Maximum | 2 | 2,000 | ₹2,46,000 |
S-HNI Minimum | 3 | 3,000 | ₹3,69,000 |
Asston Pharmaceuticals IPO Details
IPO Open Date: | July 9, 2025 |
IPO Close Date: | July 11, 2025 |
Face Value: | ₹10 Per Equity Share |
IPO Price Band: | ₹115 to ₹123 Per Share |
Issue Size: | Approx ₹27.56 Crores |
Fresh Issue: | Approx ₹27.56 Crores |
Issue Type: | Book Build Issue |
IPO Listing: | BSE SME |
Retail Quota: | Not more than 35% |
QIB Quota: | Not more than 50% |
NII Quota: | Not more than 15% |
Asston Pharmaceuticals IPO Valuation – FY2025 (KPI)
Review the valuation metrics of Asston Pharmaceuticals IPO, including key figures such as Earnings Per Share (EPS), Price-to-Earnings (P/E) Ratio, Return on Net Worth (RoNW), and Net Asset Value (NAV).
KPI | Values |
ROE: | 50.56% |
ROCE: | 51.25% |
EBITDA Margin: | 24.60% |
PAT Margin: | 17.27% |
Debt to equity ratio: | 0.68 |
Earning Per Share (EPS): | ₹6.90 (Basic) |
Price/Earning P/E Ratio: | N/A |
Return on Net Worth (RoNW): | 40.36% |
Net Asset Value (NAV): | ₹17.09 |
Asston Pharmaceuticals IPO Company Financial Report
The company posted a revenue of ₹25.61 crores in FY 2025, marking a significant rise from ₹15.84 crores recorded in FY 2024. Net profit also saw substantial growth, reaching ₹4.33 crores in 2025 compared to ₹1.36 crores in the previous financial year.
(Amount in ₹ Crores)
Period Ended | Revenue | Expense | Profit After Tax | Assets |
2023 | ₹7.19 | ₹5.78 | ₹1.06 | ₹13.69 |
2024 | ₹15.84 | ₹14.02 | ₹1.36 | ₹20.26 |
2025 | ₹25.61 | ₹19.91 | ₹4.33 | ₹28.12 |
May 2025 | ₹6.21 | ₹4.44 | ₹1.32 | ₹31.83 |
Asston Pharmaceuticals IPO Dates
The Asston Pharmaceuticals IPO will open for subscription on July 9, 2025, and will close on July 11, 2025. The share allotment is expected to be finalized by July 14, with the company’s shares scheduled to be listed on the BSE on July 16, 2025.
IPO Open Date: | July 9, 2025 |
IPO Close Date: | July 11, 2025 |
Basis of Allotment: | July 14, 2025 |
Refunds: | July 15, 2025 |
Credit to Demat Account: | July 15, 2025 |
IPO Listing Date: | July 16, 2025 |
Promoters of Asston Pharmaceuticals IPO
The promoters of the company are Dr. Ashish Narayan Sakalkar, Saili Jayaram More and Sachin Chandrakant Badakh.
About Asston Pharmaceuticals IPO
To be updated soon
Peer Group Comparison
Company | EPS | PE Ratio | RoNW % | NAV | Income |
Shelter Pharma Limited | 6.26 | 6.70 | 16.94% | 36.96 | – Cr. |
Bafna Pharmaceuticals Limited | 1.76 | 51.38 | 4.89% | 35.86 | – Cr. |
Trident Lifeline Limited | 11.35 | 25.29 | 19.85% | 57.16 | – Cr. |
Objects of the IPO
To invest in machinery and equipment to enhance the company’s manufacturing capabilities
To support the growing working capital needs of the business
To repay, either partially or fully, some of the existing loans taken by the company
To meet general corporate expenses and business growth initiatives
Merchant Bankers
- Sobhagya Capital Options Ltd
Company Address
Asston Pharmaceuticals Limited
4th Floor, Office No. A-431 Balaji Bhavan,
Plot No 42A Sector-11 CBD Belapur,
Navi Mumbai, Thane
Navi Mumbai, Maharashtra, 400614
Phone: +91 22 49731411
Email: [email protected]
Website: http://www.asstonpharmaceuticals.com/
Asston Pharmaceuticals IPO Registrar
Maashitla Securities Private Limited
Phone: +91-11-45121795-96
Email: [email protected]
Website: https://maashitla.com/allotment-status/public-issues
Check Grey market premium at below
(GMP)